These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2898864)

  • 21. Pharmacological evaluation of selected arylpiperazines with atypical antipsychotic potential.
    Tomić M; Kundaković M; Butorović B; Janać B; Andrić D; Roglić G; Ignjatović D; Kostić-Rajacić S
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4263-6. PubMed ID: 15261283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is amisulpride an 'atypical' atypical antipsychotic agent?
    Lecrubier Y
    Int Clin Psychopharmacol; 2000 Dec; 15 Suppl 4():S21-6. PubMed ID: 11252520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: evidence against dopamine receptor multiplicity.
    Scatton B
    J Pharmacol Exp Ther; 1982 Jan; 220(1):197-202. PubMed ID: 6118430
    [No Abstract]   [Full Text] [Related]  

  • 24. Dopamine autoreceptor agonists as potential antipsychotics. 1. (Aminoalkoxy)anilines.
    Jaen JC; Wise LD; Heffner TG; Pugsley TA; Meltzer LT
    J Med Chem; 1988 Aug; 31(8):1621-5. PubMed ID: 2899647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipsychotic drug action: clinical, biochemical, and pharmacological evidence for site specificity of action.
    Borison RL; Hitri A; Blowers AJ; Diamond BI
    Clin Neuropharmacol; 1983 Jun; 6(2):137-50. PubMed ID: 6133618
    [No Abstract]   [Full Text] [Related]  

  • 26. Site-specific blockade of dopamine receptors by neuroleptic agents in human brain.
    Borison RL; Fields JZ; Diamond BI
    Neuropharmacology; 1981 Dec; 20(12B):1321-2. PubMed ID: 6119643
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term effects of neuroleptics.
    Adv Biochem Psychopharmacol; 1980; 24():1-607. PubMed ID: 6105766
    [No Abstract]   [Full Text] [Related]  

  • 28. Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior.
    Butini S; Gemma S; Campiani G; Franceschini S; Trotta F; Borriello M; Ceres N; Ros S; Coccone SS; Bernetti M; De Angelis M; Brindisi M; Nacci V; Fiorini I; Novellino E; Cagnotto A; Mennini T; Sandager-Nielsen K; Andreasen JT; Scheel-Kruger J; Mikkelsen JD; Fattorusso C
    J Med Chem; 2009 Jan; 52(1):151-69. PubMed ID: 19072656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New antipsychotic agents with serotonin and dopamine antagonist properties based on a pyrrolo[2,1-b][1,3]benzothiazepine structure.
    Campiani G; Nacci V; Bechelli S; Ciani SM; Garofalo A; Fiorini I; Wikström H; de Boer P; Liao Y; Tepper PG; Cagnotto A; Mennini T
    J Med Chem; 1998 Sep; 41(20):3763-72. PubMed ID: 9748351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug effects on pre- and postsynaptic dopamine receptors.
    Andén NE; Grabowska-Andén M
    Adv Biochem Psychopharmacol; 1980; 24():57-64. PubMed ID: 6105802
    [No Abstract]   [Full Text] [Related]  

  • 31. [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties].
    Arushanian EB
    Farmakol Toksikol; 1982; 45(5):118-26. PubMed ID: 6128251
    [No Abstract]   [Full Text] [Related]  

  • 32. Receptor plasticity: biochemical correlates and pharmacological significance.
    Costa E
    Adv Biochem Psychopharmacol; 1980; 24():363-77. PubMed ID: 6105787
    [No Abstract]   [Full Text] [Related]  

  • 33. [Some pharmacological aspects of neuroleptics (author's transl)].
    Niemegeers CJ
    Encephale; 1981; 7(3):215-24. PubMed ID: 6116591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug treatment of schizophrenia.
    Silverstone T
    N Z Med J; 1994 Apr; 107(976):145-6. PubMed ID: 7909363
    [No Abstract]   [Full Text] [Related]  

  • 35. Further evidence for the existence of multiple receptors for dopamine in the central nervous system.
    Iversen LL; Quik M; Emson PC; Dowling JE; Watling KJ
    Adv Biochem Psychopharmacol; 1980; 21():193-202. PubMed ID: 6103646
    [No Abstract]   [Full Text] [Related]  

  • 36. [Neuroplegics and neuroleptics. Antipsychotics. VI. Butyrophenones (Part I)].
    Deligné P; Bunodière M
    Ann Anesthesiol Fr; 1979; 20(2):147-59. PubMed ID: 38710
    [No Abstract]   [Full Text] [Related]  

  • 37. [Etiology of schizophrenia: neurochemical aspects].
    de las Cuevas Castresana C; González de Rivera JL
    Neurologia; 1994 Feb; 9(2):54-9. PubMed ID: 7515627
    [No Abstract]   [Full Text] [Related]  

  • 38. [How do clozapine and co. work? Pharmacologic mechanisms of atypical neuroleptics].
    Müller WE
    Pharm Unserer Zeit; 2002; 31(6):537-45. PubMed ID: 12481511
    [No Abstract]   [Full Text] [Related]  

  • 39. Supersensitivity of pituitary dopamine receptors involved in the inhibition of prolactin secretion.
    Annunziato L; Quattrone A; Schettini G; Di Renzo G
    Adv Biochem Psychopharmacol; 1980; 24():379-85. PubMed ID: 6105788
    [No Abstract]   [Full Text] [Related]  

  • 40. 5-HT3 antagonists and ligands for dopamine D1- and autoreceptors offer new leads for antipsychotic drugs.
    Abbott A
    Trends Pharmacol Sci; 1990 Feb; 11(2):49-51. PubMed ID: 1969187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.